| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032748409 |
| P356 | DOI | 10.1186/1471-2334-10-217 |
| P932 | PMC publication ID | 2920872 |
| P698 | PubMed publication ID | 20663130 |
| P5875 | ResearchGate publication ID | 45388096 |
| P2093 | author name string | Rong Li | |
| Xiaoping Chen | |||
| Lunan Yan | |||
| Dawei Liu | |||
| Zhiyong Wu | |||
| Yunsong Yu | |||
| Jufang Wu | |||
| Yingyuan Zhang | |||
| Zhiwei Quan | |||
| Jianwei Bi | |||
| Zhangjing Chen | |||
| Xiaochun Ma | |||
| Xisheng Leng | |||
| Angel Cooper | |||
| Junming Wei | |||
| Robert Maroko | |||
| P2860 | cites work | Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects | Q29398341 |
| The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data | Q30998307 | ||
| Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam | Q34123811 | ||
| Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers | Q34585920 | ||
| New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors | Q34866630 | ||
| The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations | Q35051056 | ||
| Intensive care unit management of intra-abdominal infection. | Q35218495 | ||
| The pharmacokinetic and pharmacodynamic profile of tigecycline | Q36218318 | ||
| Tigecycline: a novel glycylcycline antibiotic | Q36379330 | ||
| Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program | Q36425049 | ||
| Tigecycline: a critical analysis | Q36534862 | ||
| Empiric treatment options in the management of complicated intra-abdominal infections. | Q36937012 | ||
| Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | Q40558538 | ||
| In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America | Q42162080 | ||
| Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia | Q46571176 | ||
| The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam | Q46634329 | ||
| Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial | Q46649846 | ||
| Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit | Q46654689 | ||
| Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates | Q46654692 | ||
| In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). | Q46654694 | ||
| Baseline in vitro activity of tigecycline among key bacterial pathogens exhibiting multidrug resistance | Q46731353 | ||
| Tigecycline is efficacious in the treatment of complicated intra-abdominal infections. | Q50161651 | ||
| Tertiary Peritonitis: Clinical Features of a Complex Nosocomial Infection | Q61440618 | ||
| Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery | Q80477399 | ||
| P921 | main subject | imipenem/cilastatin | Q6004128 |
| P304 | page(s) | 217 | |
| P577 | publication date | 2010-07-21 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial | |
| P478 | volume | 10 |
| Q60310408 | A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China |
| Q38255278 | Bacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis |
| Q47223062 | Busting the Myth of "Static vs. Cidal": A Systemic Literature Review |
| Q90437573 | Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials |
| Q42931315 | Clarification to the systematic review and meta-analysis involving tigecycline |
| Q36210431 | Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections |
| Q92341709 | Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI) |
| Q37904495 | Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis |
| Q26797442 | Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs |
| Q37891606 | Efficacy and safety of tigecycline: a systematic review and meta-analysis |
| Q47129511 | Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials |
| Q43770717 | Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study. |
| Q21146707 | Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options |
| Q36115632 | Excess deaths associated with tigecycline after approval based on noninferiority trials |
| Q34255044 | In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa |
| Q37723303 | Signal Detection of Imipenem Compared to Other Drugs from Korea Adverse Event Reporting System Database |
| Q33776590 | Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease |
| Q28076402 | The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties |
| Q33770721 | Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting |
Search more.